Presentation TCT 2016 FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu October 31, 2016
Presentation TCT 2016 TCT 11: Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary X-ray Angiography in the International Multicenter FAVOR (Functional Assessment by Various FlOw Reconstructions) Pilot Study Presenter: Daniel S. Berman, Pamela S. Douglas, Shengxian Tu October 31, 2016
Presentation TCT 2016 FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo October 31, 2016
Presentation TCT 2016 MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth October 31, 2016
Presentation TCT 2016 TCT 10: Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study Presenter: Daniel S. Berman, Pamela S. Douglas, Jelmer Westra October 31, 2016
Presentation TCT 2016 FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Alexandre Abizaid October 31, 2016
Presentation TCT 2016 TCT 9: A Per-Vessel Level Systematic Review of Computed Tomography-Derived FFR (FFR-CT) Diagnostic Accuracy Studies: Implications for Clinical Decision-making Presenter: Daniel S. Berman, Pamela S. Douglas, Justin E. Davies October 31, 2016
Presentation TCT 2016 REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley October 31, 2016
Presentation TCT 2016 TCT 118: Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization After Out of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia Presenter: Michel R. Le May, Ivan C. Rokos October 31, 2016
Presentation TCT 2016 Left Main Stenting: Fascinating Cases and Lessons From the EXCEL Angiographic Core Lab Presenter: David E. Kandzari, Jens Flensted Lassen, Philippe Généreux October 30, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Conference News TCT 2016 ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI Shelley Wood October 30, 2016
Presentation TCT 2016 Coronary Angiography: Set-up, Views, Artifacts, and Pitfalls Presenter: George D. Dangas, Vijay Kunadian, Philippe Généreux October 29, 2016
Presentation Stanford Coronary Physiology Conference 2016 Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial Presenter: William F. Fearon October 28, 2016
Presentation Stanford Coronary Physiology Conference 2016 FFR-Guided PCI Vs Medical Therapy: FAME 2 and Substudies Presenter: Bernard De Bruyne October 28, 2016
Presentation Stanford Coronary Physiology Conference 2016 Assessing Chest Pain and Non-obstructive CAD Presenter: Jennifer A. Tremmel October 28, 2016
Presentation Stanford Coronary Physiology Conference 2016 FFR in Multivessel Disease: FAME-1 and Substudies Presenter: Nico H. J. Pijls October 28, 2016
News Daily News STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy L.A. McKeown October 05, 2016
News Daily News Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI Michael O'Riordan October 03, 2016
Presentation ESC 2016 CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT) Presenter: John P. Greenwood August 29, 2016